Fulcrum Therapeutics
FULC
FULC
122 hedge funds and large institutions have $374M invested in Fulcrum Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 117 → 122 (+5)
26% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 46
Holders
122
Holding in Top 10
2
Calls
$6.27M
Puts
$643K
Top Buyers
| 1 | +$8.5M | |
| 2 | +$7.16M | |
| 3 | +$3.96M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.66M |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$2.34M | |
| 3 | -$1.77M | |
| 4 |
Renaissance Technologies
New York
|
-$1.73M |
| 5 |
EAM
Exome Asset Management
New York
|
-$1.31M |